Search results
Earnings call: Adaptimmune outlines afami-cel launch and financials By Investing.com
Investing.com· 3 hours agoAdaptimmune Therapeutics PLC (NASDAQ:ADAP), a biotechnology company specializing in T-cell therapy,...
Car T-Cell Therapy
WNDU 16 South Bend· 2 days agoMedical experts call it a ‘breakthrough’ and ‘gamechanger’ when it comes to cancer treatment. “Immunotherapy has really come on as quite an advance in...
Tumor tissue on a chip: New possibilities for cell therapies and personalized medicine
Medical Xpress· 4 hours ago"This allows us to individually investigate how exactly these tumor cells react to the planned therapy, what side effects may be expected and how these can be reduced," explains ...
Engineered CD47 protects T cells for enhanced antitumour immunity - Nature
Nature· 13 hours agoCombination of TCR or CAR T cells expressing the engineered CD47 variant 47E with anti-CD47 antibody therapy results in synergistic antitumour efficacy due to T< ...
...Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad...
FOX 4 Kansas City· 3 days ago...Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious...
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of...
FOX 23 News Albany· 5 days agoOn May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of...
Earnings call: Fate Therapeutics reports on clinical progress and finances By Investing.com
Investing.com· 2 days agoThe company's FT819 CAR T-cell therapy showed promise for B-cell-mediated autoimmune diseases, with...
...on Successful Use of Applied DNA’s Linea DNATM for the Non-Viral Manufacture of CAR T-Cell ...
The Kansas City Star· 2 days agoAccepted abstracts...
Adaptimmune secures $125 million loan for cancer therapy By Investing.com
Investing.com· 3 hours agoAdaptimmune Therapeutics plc (NASDAQ: NASDAQ:ADAP), a biopharmaceutical firm specializing in cell ...
Cytiva: 'BIO is a very important convention for us'
BioPharma-Reporter· 7 hours agoLife sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for autologous CAR-T cell therapies....